Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06261736 · ClinicalTrials.gov registry record · NA

The Effectiveness of Prophylactic Antibiotics for Urethral Bulking

A NA study of Stress Urinary Incontinence and Postoperative Urinary Tract Infection, sponsored by Atlantic Health System.

Recruiting
Registry status
NA
Development phase
70
Enrollment target
1
Study location

NCT06261736 is a NA study of Stress Urinary Incontinence and Postoperative Urinary Tract Infection that is actively recruiting participants, run by Atlantic Health System. The registered enrollment target is 70 participants, below the 161-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06261736, a NA study of Stress Urinary Incontinence and Postoperative Urinary Tract Infection, is actively recruiting participants, sponsored by Atlantic Health System.

RECRUITING
Registry status
NA
Development phase
70 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to evaluate if prophylactic antibiotics in urethral bulking are effective in reducing postprocedural urinary tract infections.

Interventions

  • OTHER Prophylactic antibiotics
  • OTHER No antibiotics

Study Locations (1)

New Jersey

  • Atlantic Health - Morristown

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2023-10-24
Est. Completion 2026-01
Phase NA

Sponsor

Atlantic Health System

43 total trials

What the Registry Record Tells You About NCT06261736

The ClinicalTrials.gov registry entry for NCT06261736 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 161-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (57% lower). The listed sponsor is Atlantic Health System, which has 43 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Prophylactic antibiotics is the first listed.

NCT06261736 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06261736 about?

NCT06261736 is a clinical study titled "The Effectiveness of Prophylactic Antibiotics for Urethral Bulking". The goal of this clinical trial is to evaluate if prophylactic antibiotics in urethral bulking are effective in reducing postprocedural urinary tract infections.

What is the current status of trial NCT06261736?

This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-10-24. Estimated completion is 2026-01.

What conditions does trial NCT06261736 study?

This clinical trial studies the following conditions: Stress Urinary Incontinence, Postoperative Urinary Tract Infection, Urethral Bulking.

What interventions are being tested in trial NCT06261736?

The interventions under investigation include: Prophylactic antibiotics (OTHER), No antibiotics (OTHER).

Who is sponsoring clinical trial NCT06261736?

This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06261736 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.